Across TCGA cell cohorts, NAP1L2 mutation is significantly associated with the RNA expression of many other genes, with 3 significant associations in total. LUNG_NSCLC_LUAD shows the largest number of these associations.

The most reproducible NAP1L2-associated genes across cancer lineages are PTH, CD300LD, and C7orf33. Each is linked with NAP1L2 in more than 1 cancer types. Because this analysis shows association rather than direction, both NAP1L2-to-partner and partner-to-NAP1L2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAP1L2→partner) and Y-score (partner→NAP1L2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUNG_NSCLC_LUAD	PTH →	+0.020	+3.887	<.001	.002	3	1
LUNG_NSCLC_LUAD	CD300LD →	+0.047	+3.362	.006	.007	3	1
BREAST	C7orf33 →	+0.209	+5.169	<.001	.005	3	1

Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Exploration

NAP1L2 survival (RNA) · tumor vs normal (RNA) · all NAP1L2 data types